The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog FDA's accelerated approval process: What your audience needs to know Sleep & Sculpt Peptide Therapy in Chicago CJC1295 + Ipamorelin at Better Med Spa